Humana Inc HUM
We take great care to ensure that the data presented and summarized in this overview for HUMANA INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding HUM
View all-
Vanguard Group Inc Valley Forge, PA11MShares$3.94 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY11MShares$3.93 Billion0.09% of portfolio
-
State Street Corp Boston, MA5.3MShares$1.9 Billion0.09% of portfolio
-
Wellington Management Group LLP Boston, MA4.6MShares$1.65 Billion0.31% of portfolio
-
Dodge & Cox San Francisco, CA4.31MShares$1.54 Billion1.02% of portfolio
-
Eagle Capital Management LLC New York, NY3.23MShares$1.16 Billion4.62% of portfolio
-
Geode Capital Management, LLC Boston, MA2.82MShares$1.01 Billion0.09% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.67MShares$956 Million0.12% of portfolio
-
Richard Pzena Pzena Investment Management LLC2.32MShares$830 Million3.09% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az2.31MShares$828 Million5.01% of portfolio
Latest Institutional Activity in HUM
Top Purchases
Top Sells
About HUM
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Insider Transactions at HUM
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 01
2024
|
George Renaudin Ii President, Medicare & Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
303
-2.79%
|
$106,656
$352.14 P/Share
|
Sep 01
2024
|
George Renaudin Ii President, Medicare & Medicaid |
BUY
Exercise of conversion of derivative security
|
Direct |
1,241
+10.25%
|
-
|
Aug 01
2024
|
John Paul W. Felter SVP, Chief Accting Off & Cont. |
SELL
Payment of exercise price or tax liability
|
Direct |
63
-6.83%
|
$22,491
$357.32 P/Share
|
Aug 01
2024
|
John Paul W. Felter SVP, Chief Accting Off & Cont. |
BUY
Exercise of conversion of derivative security
|
Direct |
210
+18.53%
|
-
|
Aug 01
2024
|
Susan M Diamond Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
142
-0.71%
|
$50,694
$357.32 P/Share
|
Aug 01
2024
|
Susan M Diamond Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
311
+1.52%
|
-
|
Feb 22
2024
|
William Kevin Fleming Chief Corporate Aff. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,226
-10.61%
|
$448,716
$366.11 P/Share
|
Feb 22
2024
|
William Kevin Fleming Chief Corporate Aff. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,566
+23.59%
|
-
|
Feb 22
2024
|
Samir Deshpande Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,302
-9.51%
|
$476,532
$366.11 P/Share
|
Feb 22
2024
|
Samir Deshpande Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,770
+21.58%
|
-
|
Feb 22
2024
|
Bruce D Broussard Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,473
-8.75%
|
$3,101,118
$366.11 P/Share
|
Feb 22
2024
|
Bruce D Broussard Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,572
+18.91%
|
-
|
Feb 22
2024
|
Vishal Agrawal Chief Strat & Corp Dev Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
959
-8.1%
|
$350,994
$366.11 P/Share
|
Feb 22
2024
|
Vishal Agrawal Chief Strat & Corp Dev Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,010
+20.26%
|
-
|
Feb 22
2024
|
Timothy S. Huval Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,284
-14.8%
|
$469,944
$366.11 P/Share
|
Feb 22
2024
|
Timothy S. Huval Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,712
+29.97%
|
-
|
Feb 22
2024
|
Joseph C Ventura Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,153
-14.09%
|
$421,998
$366.11 P/Share
|
Feb 22
2024
|
Joseph C Ventura Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,411
+29.43%
|
-
|
Feb 22
2024
|
Susan M Diamond Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,125
-15.13%
|
$411,750
$366.11 P/Share
|
Feb 22
2024
|
Susan M Diamond Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,356
+31.1%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 81.4K shares |
---|---|
Open market or private purchase | 545 shares |
Exercise of conversion of derivative security | 61.5K shares |
Payment of exercise price or tax liability | 22.6K shares |
---|---|
Bona fide gift | 600 shares |